A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Recruiting · NCT06655324 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001). | Healthy | Recruiting | Phase 1 | 2026-09-17 | NCT06655324 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alliance for Multispecialty Research, LLC ( Site 0008) | Kansas City | United States | 1 |
| Alliance for Multispecialty Research, LLC ( Site 0009) | Knoxville | United States | 1 |
| Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0016) | Springfield | United States | 1 |
| California Clinical Trials Medical Group managed by PAREXEL ( Site 0011) | Glendale | United States | 1 |
| Lynn Health Science Institute ( Site 0010) | Oklahoma City | United States | 1 |
| QPS-MRA, LLC ( Site 0012) | South Miami | United States | 1 |
| Remington-Davis, Inc. ( Site 0017) | Columbus | United States | 1 |
| Velocity Clinical Research Lincoln ( Site 0004) | Lincoln | United States | 1 |
| Velocity Clinical Research, Omaha ( Site 0005) | Omaha | United States | 2 |